Table 2.
Diseases | Pharmacological Effects | AN Components | Mechanism | Biological Materials | References |
---|---|---|---|---|---|
Gastric and intestine | against gastric cancer cell | 15.91 μM 2,4-Compound 26, 20.13 μM Compound 34 | BGC-823 cells | [70] | |
esophageal sphincter muscle contractions ↑ | 300 ng/L AN pericarp extracts, 300 nM arecoline | porcine | [71] | ||
Depression and anxiety | antidepression | 141 depression-related genes | [72] | ||
anxiolytic-like activity | 10 mg/L arecoline | ↑ c-fos, c-jun, egr2 and ym1 | zebrafish | [73] | |
Liver | hepatocellular carcinoma progression ↓ | 20~30 µg/mL or 20 mg/kg AN extract | ↑ autophagy and apoptosis | HepJ5 and Mahlavu cells, nude mice | [74] |
Nerve | dopaminergic neuron firing rate ↑ | 0.2 mg/kg arecoline | ↑ dopaminergic | rats | [75] |
synaptic exocytosis at neuromuscular junctions ↑ | 0.2 mM arecoline | ↑ GAR-2/PLCβ pathway | C. elegans. | [76] | |
improving cognition, memory and behavioral disorders | arecoline | ↑ muscarinic M1 receptors | human | [77] | |
Bacterial infection | antibacterial effects | 1–100 mg/mL AN extracts | S. aureus, E. aerogenes, E. coli, S. enterica | [78] | |
against Staphylococcus aureus | 1000 mg/kg BW AN extracts | S. aureus, rats | [79] | ||
against Mycobacterium tuberculosis, Staphylococcus aureus, Escherichia coli | 0.975 ± 0.02 μg/mL AN extracts | M. tuberculosis, S. aureus, E. coli. | [80] | ||
antimicrobial activity of nine Gram-negative, Gram-positive bacteria and yeast | 10.3 ± 1.1–40.0 ± 3.0 AN SHDE extract | B. subtilis, E. faecalis, E. coli, P. aeruginosa, S. aureus, S. agalactiae, S. canis, S. pyogenes, Candida albicans | [81] | ||
Skin protection | UVB-induced photoaging ↓ | AN procyanidins | ↓ COX-2, MMPs | mice | [82] |
tyrosinase and elastase inhibition | 295.79 ± 11.97 mg/g dry weight AN extract | ↓ Tyrosinase, elastase | [83] | ||
Anthelmintic activity | against the nematode Ascaridia galli | 250 mg/mL, 100 mg/mL AN extract | Ascaridia galli, chicken | [84] | |
against the fluke Fasciola spp. | 10%, 20%, 40% AN extract | Fasciola spp., buffaloes | [85] | ||
Antioxidant | antioxidant | 2 mg/mL PAP1b | ↓ hydroxyl radicals | [86] | |
antioxidant | 20 µL AN extract | ↓ free radical | [83] | ||
Anti-hypoxia | protecting effects caused by hypoxia | AN polyphenols | ↓ free radicals | [87] | |
Anti-osteoarthritis | suppressed inflammation | 1 and 10 mg/kg/day AN ethanol extract | ↓ iNOS, COX-2 | rats | [88] |
↑: Activated, ↓: Inhibited.